First data published in new Medicines in Pregnancy Registry
The first publication includes data on valproate use by females aged 0 to 54 years, in England, from April 2018 to September 2020.
Valproate is a treatment for epilepsy and bipolar disorder which is known to cause harm to unborn children. The report provides information on prescribing in relation to pregnancies recorded in the registry. It does not provide a comprehensive review of the number of females affected.
NHS Digital is working in partnership with the Medicines and Healthcare products Regulatory Agency (MHRA) to develop Medicines in Pregnancy Registries in response to the Cumberlege Review1.
The registries will provide the health and care system with the insights needed to track outcomes and make informed clinical decisions around the prescribing of medicines during pregnancy. They will also enable medicines regulators to monitor prescribing practices and adherence to pregnancy prevention programmes.
This report uses data from existing patient level administrative datasets specifically Medicines dispensed in Primary Care2 linked to the Maternity Services Data Set (MSDS) and Hospital Episode Statistics (HES) data.
This report is not an investigation but is an analysis of existing administrative patient data to enable the health system to understand the care and outcomes for these patients and consequently to improve patient care. Any gaps identified in the data will help inform the future development of clinical registry functions for medicine registries.
The core register for the valproate registry, which is the subject of this report, will be extended to all antiepileptics and provide a basis to develop medicines in pregnancy registries in other clinical areas.
Notes for editors
- The Cumberlege report can be found here: the Independent Medicines and Medical Devices safety Review - Oral hearings (immdsreview.org.uk)
- The Medicines dispensed in Primary Care data is a monthly collection of patient level data about medicines dispensed and claimed for in community settings (primarily community pharmacy) from the NHS Business Services Authority (NHSBSA): Medicines dispensed in Primary Care NHS Business Services Authority data - NHS Digital
Latest News from
NHS e-Referral Service integrated into the NHS App to make managing referrals easier01/04/2021 16:15:00
Patients are now able to easily and safely book and manage their e-RS referrals through the NHS App, reducing non-attendance of appointments and saving GPs’ time.
Sarah Wilkinson to step down as CEO of NHS Digital after 4 years29/03/2021 15:43:00
The Board of NHS Digital regrets to announce that Sarah Wilkinson has resigned as CEO of NHS Digital and will leave the organisation in the summer.
New overview of adult social care statistics is published by NHS Digital26/03/2021 16:15:00
A new report was yesterday published which uses NHS Digital’s adult social care statistics to show trends over time.
NHS Digital celebrates International Women’s Day08/03/2021 13:43:00
International Women’s Day is a global day celebrating the social, economic, cultural and political achievements of women, as well as highlighting and challenging gender inequality that women continue to face.
Latest figures on registered blind and partially sighted people in England are published26/02/2021 11:10:00
Statistics on the number of blind and partially sighted people who registered with their local authority during 2019-20 have been published by NHS Digital.
Improvements to the advice function on NHS e-Referral service makes referring easier17/02/2021 12:15:00
Following feedback from GPs and consultants, NHS Digital has improved the NHS e-Referral Service (e-RS), to make referring smoother and easier for all.
Lifesaving coronavirus treatment discovered by study using data from NHS Digital12/02/2021 11:15:00
Data from NHS Digital has helped researchers discover that an anti-inflammatory drug reduces the risk of death in patients with severe coronavirus (COVID-19).